Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 02/11/2020

    CureVac Reports Positive Interim Phase 1 Data for its COVID-19 Vaccine Candidate, CVnCoV

    CureVac N.V. (Nasdaq: CVAC), a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced positive interim data from its ongoing Phase 1 dose-escalation study evaluating the safety, reactogenicity and immunogenicity of CVnCoV, its investigational SARS-CoV-2 vaccine candidate.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-reports-positive-interim-phase-1-data-its-covid-19-vaccine-candidate-cvncov
  • Press release - 08/10/2020

    New class of highly effective inhibitors protects against neurodegeneration

    Heidelberg neurobiologists decode central mechanism of degenerative processes in the brains of mouse models and develop new principle for therapeutic agents.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-class-highly-effective-inhibitors-protects-against-neurodegeneration
  • Article - 03/04/2019 team.jpg

    HKK Bionics empowers hand gripping functions

    A spin-off from the Ulm University of Applied Sciences is aiming to provide people whose hands have been paralysed due to accident or illness with a new kind of orthopaedic aid. Dominik Hepp and Tobias Knobloch are currently starting serial production of a hand orthosis prototype. The two medical engineers from Ulm, who founded HKK Bionics GmbH in 2017, plan to commence final tests in 2019.

    https://www.gesundheitsindustrie-bw.de/en/article/news/hkk-bionics-empowers-hand-gripping-functions
  • Article - 21/02/2019 Teaser_Kellmeyer_Bild_2.PNG_.png

    Using neuromedical artificial intelligence responsibly

    Brain-computer interfaces are the latest developments in the neurotechnology field. They are used to record brain activity, which is then decoded with artificial intelligence techniques and converted into control signals for robots or computers. While this brings hope to severely paralysed people, it also implies risks due to the interest of companies like Google and Facebook in this type of data.

    https://www.gesundheitsindustrie-bw.de/en/article/news/using-neuromedical-artificial-intelligence-responsibly
  • Article - 21/08/2018 Cells stained blue and red.

    Parkinson's disease: vitamin B3 has a positive effect on nerve cells

    Parkinson's disease is one of the most common neurodegenerative diseases in the world. There are around 4.1 million sufferers worldwide. It is characterised by motor impairments that result from the death of certain nerve cells in the brain. Researchers at the University of Tübingen have now discovered that vitamin B3 has a positive effect on damaged nerve cells and can boost their energy metabolism.

    https://www.gesundheitsindustrie-bw.de/en/article/news/parkinsons-disease-vitamin-b3-has-a-positive-effect-on-nerve-cells
  • Press release - 04/07/2018 The collagen membrane „Collagen Cell Carrier“ is thin, elastic, yet robust and biocompatible.

    Phase-I-trial approved for novel stem cell therapy for patients with ischemic cardiomyopathy

    Viscofan BioEngineering, the biomedical business unit of the world market leader for collagenous sausage casings Viscofan announced today that the Spanish Agency for Medicines (AEMPS) has given green light to carry out a clinical phase-I-trial with Viscofan BioEngineering’s first product for regenerative medicine. The novel therapy consisting of stem cells on a collagenous carrier membrane can now be tested on ten patients suffering from severe…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/phase-i-trial-approved-for-novel-stem-cell-therapy-for-patients-with-ischemic-cardiomyopathy
  • Article - 16/05/2018 Porträtbild von Prof. Bardutzky.

    Telemedical neurology council helps speed up stroke treatment

    Stroke units save lives because specialist treatment is absolutely crucial for stroke patients. However, not all clinics have neurological specialists available 24/7, so telemedicine provides a good solution to the problem. Studies show that telemedical consultations can considerably improve the treatment of stroke patients.

    https://www.gesundheitsindustrie-bw.de/en/article/news/telemedical-neurology-council-helps-speed-up-stroke-treatment
  • Article - 13/11/2017 Two scientists in the laboratory holding and looking at an artificial heart valve.

    An artificial heart valve with the potential to grow

    About 30,000 artificial heart valves are implanted in Germany every year. The durability of these heart valves presents a major challenge, requiring them to be exchanged time and again, especially in young patients. Researchers from the Stuttgart Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB have developed a new artificial heart valve material on which cells that are naturally present in a patient’s blood can form new…

    https://www.gesundheitsindustrie-bw.de/en/article/news/an-artificial-heart-valve-with-the-potential-to-grow
  • Press release - 05/09/2017 PET-Gerat-Uni-Tubingen.jpg

    Cell marking opens up a window into the body

    A new and particularly reliable method for marking cells can simplify research into diseases such as myocardial infarction, diabetes or Alzheimer's and reduce the use of test animals: Scientists from the University of Tübingen have developed a method by which they can target specific cell types in mice and monitor their behavior using positron emission tomography (PET). PET-based cell tracking allows scientists to observe complex life…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cell-marking-opens-up-a-window-into-the-body
  • Company profile - 14/07/2016 Schematic showing how the neurostimulator leads to the stimulation of the vagus nerve lowers the blood pressure.

    neuroloop GmbH: how the manipulation of neuronal information can lower blood pressure

    Millions of people worldwide suffer from high blood pressure. However, taking medicines to control high blood pressure does not work for everyone. Dr. Dennis Plachta and Prof. Dr. Thomas Stieglitz from IMTEK have now developed a neurostimulator to control blood pressure. Together with Dr. Michael Lauk, an experienced company founder, the two researchers set up a company called neuroloop, which is funded by Aesculap AG and aims to turn the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/neuroloop-gmbh-how-the-manipulation-of-neuronal-information-can-lower-blood-pressure
  • Article - 11/07/2016 Photo of the members of the Department of Redox Regulation.

    Endogenous oxidants: biosensor monitoring of metabolic conditions in living organisms

    The oxidation state of the cells in our body is very important for us: if the normal balance of the distribution of endogenous oxidants is disturbed or if they attack cellular structures, cells are either unable or only partially able to fulfil their functions, and diseases develop. Dr. Tobias Dick and his team of researchers at the German Cancer Research Center (DKFZ) in Heidelberg have now developed a biosensor that facilitates real-time…

    https://www.gesundheitsindustrie-bw.de/en/article/news/endogenous-oxidants-biosensor-monitoring-of-metabolic-conditions-in-living-organisms
  • Article - 12/05/2016 Grey, three-dimensional molecule model surrounded by red RNA sequences.

    Novel method for predicting the spatial structure of biomolecules

    Biomolecules can only fulfil their functions in the cell when they fold into a characteristic native three-dimensional structure. Knowing this structure is not only of paramount importance for basic research, but also for medicine and pharmacology. Scientists from the Karlsruhe Institute of Technology (KIT) have therefore developed a simple method to predict the three-dimensional structure of biomolecules from the analysis of readily available…

    https://www.gesundheitsindustrie-bw.de/en/article/news/novel-method-for-predicting-the-spatial-structure-of-biomolecules
  • Article - 02/05/2016 hv_PhaZd1__C_WT.jpg

    Biopolymers – raw materials for innovative medical products

    Polyhydroxyalkanoates (PHA) are biodegradable biopolymers that are becoming increasingly important. Bioplastics are now used not only in everyday objects such as plastic bags and yogurt pots but also increasingly in the field of medicine, which is why intensive research into medical devices made from biodegradable polymers such as PHA has been going on for quite some time.

    https://www.gesundheitsindustrie-bw.de/en/article/news/biopolymers-raw-materials-for-innovative-medical-products
  • Article - 29/03/2016 Photo of five zebrafish.

    The zebrafish can mend its own heart

    In adults, cells such as nerve or cardiac muscle cells have lost the ability to regenerate. This is why myocardial infarction is so dangerous – damaged cardiac muscle cells do not grow back and scar tissue forms in their place. Prof. Dr. Gilbert Weidinger and an international team of researchers have deciphered a mechanism responsible for the regeneration of the zebrafish heart.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-zebrafish-can-mend-its-own-heart
  • Article - 22/12/2014 22613_de.jpg

    Large-scale urology project: cell therapy for the treatment of stress incontinence

    The first and so far only clinical DFG research group on urology is being coordinated by a team from Tübingen. The team is developing a cell-based therapy for the regeneration of the urethral sphincter. Clinicians, life scientists and engineers are working together to try and find a causal therapy of stress incontinence.

    https://www.gesundheitsindustrie-bw.de/en/article/news/large-scale-urology-project-cell-therapy-for-the-treatment-of-stress-incontinence
  • Article - 15/12/2014 Schematic showing how cardiac muscle cells are prepared, and how cell nuclei and the genetic material are isolated.

    Heart muscle cell 1.0 and 2.0 – two epigenetic programmes in one cell

    All the cells in an organism have to adapt to changing requirements as they develop and grow - including muscle cells in the heart. Crucial to this process are the cells’ growth in size and epigenetic factors that play a role in modulating the expression of various genes. The role of epigenetics in cancer development has been the focus of research for quite some time. The question is, what role do epigenetic factors play in the development of the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/heart-muscle-cell-1-0-and-2-0-two-epigenetic-programmes-in-one-cell
  • Article - 18/11/2013 20653_de.jpg

    The HAE Accelerator – "compete to speed up your start-up"

    The HAE Accelerator is an international programme involving biomedical clusters in Cambridge (UK), Leuven (Belgium) and Heidelberg (Germany) that seeks to identify, train and put innovative start-up teams in the three countries in contact with international VC investors. Of the three business ideas that were awarded a HAE Investors’ Choice Award in September 2013, InoCard from Heidelberg came first with a new gene therapy for myocardial…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-hae-accelerator-compete-to-speed-up-your-start-up
  • Article - 19/08/2013 The photo shows a schematic of the brain with electrodes arranged in a coordinate system.<br />

    Brain mapping – ‘eavesdropping’ on the brain

    Although numerous scientists have spent decades exploring the brain and many things are already known the brain is still considered one of the greatest mysteries of science. While structural elements such as cell and axon distribution can only be mapped post mortem motor and sensory functions can only be studied in vivo i.e. using living organisms. Dr. Tonio Ball and his colleagues at the BrainLinks-BrainTools cluster of excellence at the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/brain-mapping-eavesdropping-on-the-brain
  • Article - 22/07/2013 20103_de.jpg

    Marcus Fändrich strengthens protein biochemistry at Ulm University

    After quite a long vacancy the directors post of the Institute for Pharmaceutical Biotechnology at the University of Ulm has finally been filled. Marcus Fändrich and his team moved into the laboratories and offices of the new life sciences building on the Oberer Eselsberg Ulm University campus in November 2012. Fändrich fills a gap in the Ulm Bioregions biopharmaceutical education activities as he will not only be teaching biochemistry…

    https://www.gesundheitsindustrie-bw.de/en/article/news/marcus-faendrich-strengthens-protein-biochemistry-at-ulm-university
  • Dossier - 01/07/2013 Patch clamping: A glass pipette is used to suck in a membrane patch of a cell. (Diagram: NMI)

    Electrophysiology – from cardiac pacemakers to drug discovery

    Electrochemical reactions are involved in many processes in the human organism. Electrophysiology is the study of the central processes of electrical and chemical interaction and communication between neurons and muscle cells, including the transmission and processing of signals in the nerves and the subsequent contraction of the muscles. For example, electrophysiology studies examine the rhythm which which our heart pumps blood through the…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/electrophysiology-from-cardiac-pacemakers-to-drug-discovery
  • Article - 03/06/2013 19684_de.jpg

    Laser light for the diagnosis of stroke

    Stroke is one of the most common causes of death in the Western world and in Germany the most common cause of moderate to severe disabilities. Besides effective prevention, the rapid and specific diagnosis of impaired blood circulation in the brain is key in the effective treatment of stroke patients. PD Dr. Thomas Gisler from the University of Konstanz has developed CereFLux, a method that allows the flow of blood in the human brain to be…

    https://www.gesundheitsindustrie-bw.de/en/article/news/laser-light-for-the-diagnosis-of-stroke
  • Article - 15/04/2013 19500_de.jpg

    Price pressure requires new product developments – the "Bioactive Plant Foods" network

    The Bioactive Plant Foods network which is coordinated by the Steinbeis-Europa-Zentrum in Stuttgart is focused on developing innovative products that have a positive effect on human health and placing them on the market. Research resolves around the health-promoting effect of amaranth a short-lived plant with catkin-like cymes of densely packed red flowers. More than 20 partners from industry science and marketing have been working together since…

    https://www.gesundheitsindustrie-bw.de/en/article/news/price-pressure-requires-new-product-developments-the-bioactive-plant-foods-network
  • Article - 25/03/2013 19421_de.jpg

    Ralf Baumeister – tinkering, constructing and switching off genes

    The focus of Ralf Baumeisters research a small nematode that is known as Caenorhabditis elegans is a rather simple organism. Nevertheless the worm can be used to study complicated behaviour including associated learning. This is how Prof. Dr. Ralf Baumeister from the Institute of Biology III at the University of Freiburg describes the animal that he works with on a daily basis. The worm has now got very little left to hide. And the genetic…

    https://www.gesundheitsindustrie-bw.de/en/article/news/ralf-baumeister-tinkering-constructing-and-switching-off-genes
  • Article - 18/03/2013 Electron microscope image of small S100A6 aggregates that form larger fibrils.

    Protein depositions in the brain promote the development of amyotrophic lateral sclerosis (ALS)

    Being aware of ones own physical degradation as intellect and cognition remain completely intact this is what the disease amyotrophic lateral sclerosis ALS also known as Lou Gehrigs disease means to sufferers. The disease is currently not curable as far too little is known as yet about its causes. However basic research is making progress and providing increasing insights into the causes of ALS. Dr. Günter Fritz and his colleagues from the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/protein-depositions-in-the-brain-promote-the-development-of-amyotrophic-lateral-sclerosis-als
  • Press release - 18/03/2013 19373_de.jpg

    Med Cell Europe AG: medicine from a patient’s own adipose tissue

    Med Cell Europe AG, which is headquartered in Münchwilen, Switzerland, and a member of the BioLAGO bioregion, is the only private stem cell bank in Europe that isolates adult stem cells from customers’ adipose tissue. The biotech company, which was founded in 2010, is also active in research. The focus, amongst other things, is on the transformation of stem cells into insulin-producing cells and cytotoxicity tests to explore potential damage to…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/med-cell-europe-ag-medicine-from-a-patient-s-own-adipose-tissue

Page 1 / 5

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2021
Website address: https://www.gesundheitsindustrie-bw.de/en/search